Pharmacokinetics

Pharmacokinetics (PK) describes what the organism does to an administered molecule. It quantifies absorption, tissue distribution, metabolism (primarily hepatic) and excretion (renal, biliary) processes, grouped under the ADME acronym. In preclinical peptide research, pharmacokinetics is the first reading grid for comparing two analogues, anticipating dosing frequency and interpreting observed biological responses.

Fundamental PK parameters include bioavailability (fraction of dose reaching systemic circulation), elimination half-life (t½), volume of distribution (Vd, reflecting tissue penetration), clearance (plasma volume cleared per unit time) and area under the curve (AUC, total exposure). These metrics are obtained through sequential blood sampling after single or repeated administration, with measurement by HPLC or LC-MS/MS.

Native peptides exhibit particularly unfavorable pharmacokinetic profiles: short half-lives of minutes to hours, near-zero oral bioavailability due to gastric degradation, volume of distribution limited to the extracellular compartment. Peptide engineering strategies specifically aim to correct these limitations: acylation with fatty acids (liraglutide, semaglutide) for albumin binding and half-life extension, PEGylation, cyclization, substitution with non-natural protease-resistant amino acids (Aib, D-amino acids).

In exploratory research, pharmacokinetics guides three major decisions: optimal route of administration (subcutaneous versus intravenous versus intranasal), sampling timing to capture peak and trough concentrations, and dose extrapolation between animal species through allometric scaling. Poor understanding of PK parameters frequently leads to erroneous biological conclusions, for example attributing absence of effect to actual pharmacological inactivity when the molecule simply never reached its target tissues at sufficient concentration.

For research peptides listed on lab-peptides-france.com, pharmacokinetic data published in the scientific literature enable laboratories to build rigorous experimental protocols: administration spacing, washout duration between conditions, relevant animal model selection. Pharmacokinetics is not a theoretical supplement but the quantitative skeleton of any serious biological investigation.